Skip to main content

Restrictive vs Constrictive Cardiomyopathy


Restrictive vs Constrictive Cardiomyopathy: A Complete, Clinician-Friendly Comparison

Restrictive cardiomyopathy (RCM) and constrictive pericarditis (CP) often present with similar clinical features—especially right-sided heart failure with preserved ejection fraction. Yet their underlying pathology, diagnostic clues, and management differ drastically. Distinguishing the two is crucial because RCM is a myocardial disease, while CP is a potentially reversible pericardial disorder.


This article provides a crisp, high-yield comparison for clinicians.



---


πŸ”Ή 1. Definition


Restrictive Cardiomyopathy (RCM)


A myocardial disorder characterized by stiff, non-compliant ventricles due to infiltration or fibrosis.

→ Filling is restricted, systolic function usually preserved until late.


Constrictive Pericarditis (CP)


A pericardial disease in which a thickened, fibrotic, or calcified pericardium limits ventricular expansion.

→ Ventricles cannot fill normally due to an external shell.



---


πŸ”Ή 2. Etiology


RCM Causes


Amyloidosis (most common)


Hemochromatosis


Sarcoidosis


Endomyocardial fibrosis


Radiation-induced myocardial disease


Idiopathic or familial RCM



CP Causes


Tuberculosis (common in developing regions)


Viral pericarditis


Post-cardiac surgery


Radiation therapy


Connective tissue disorders


Idiopathic chronic pericarditis




---


πŸ”Ή 3. Pathophysiology (Key Difference)


RCM


Stiff myocardium → impaired ventricular compliance


Affects both ventricles symmetrically


Normal pericardium


Atrial enlargement is prominent



CP


Rigid pericardium → ventricles cannot expand


Ventricular interdependence (classic)


Dissociation between thoracic and intracardiac pressures


Atria may be less dilated than in RCM




---


πŸ”Ή 4. Clinical Features


Both conditions show:


Elevated JVP


Right-sided heart failure


Preserved EF


Kussmaul’s sign



But subtle differences help:


RCM


More pulmonary congestion


More severe exercise intolerance


S3 may be heard


Atrial fibrillation common


LV thickening (infiltrative diseases)



CP


Pericardial knock (early diastolic sound)


Peripheral edema often more pronounced


Ascites and hepatomegaly prominent


Cachexia in chronic cases


History of TB, surgery, or radiation




---


πŸ”Ή 5. Investigations


ECG


RCM:


Low voltage (amyloidosis)


Conduction abnormalities


Atrial enlargement


Arrhythmias common



CP:


Low voltage rare


AF common


Non-specific ST-T changes




---


Echocardiography


RCM


Normal or thickened ventricles


Marked biatrial enlargement


Normal pericardium


Doppler: restrictive filling pattern without respiratory variation



CP


Normal LV size


Septal “bounce” or “shudder”


Respiratory variation in mitral/tricuspid inflow


Inferior vena cava dilated, poor collapse


Thickened pericardium (sometimes missed)




---


Cardiac MRI


RCM


Myocardial infiltration


Late gadolinium enhancement (LGE) in typical patterns


Normal pericardium



CP


Thickened or calcified pericardium


Ventricular interdependence


Septal bounce


Real-time cine sequences show dissociation of pressures




---


Hemodynamics (Cardiac Catheterization)


RCM


No ventricular interdependence


Elevated LVEDP = RVEDP (nearly equal)


Square root sign present in some cases


Pulmonary pressures higher than in CP



CP


Marked ventricular interdependence (KEY)


Equalization of diastolic pressures (within 5 mmHg)


Prominent square root sign


Discordant LV/RV systolic pressures with respiration (defining feature)




---


πŸ”Ή 6. Management


RCM


Treat underlying cause


Diuretics for congestion


Avoid aggressive preload reduction


Disease-specific therapies:


Tafamidis (ATTR amyloidosis)


Iron chelation (hemochromatosis)


Steroids (sarcoidosis if active)



Advanced cases: heart transplant



CP


Diuretics temporarily


Definitive treatment: Pericardiectomy


Excellent prognosis if performed early


Avoid in active inflammatory phase (unless unavoidable)




---


πŸ”Ή 7. Prognosis


RCM


Progressive, worse long-term survival


Depends on etiology


Amyloidosis particularly poor without targeted therapy



CP


Potentially curable


Post-pericardiectomy survival improves dramatically




---


πŸ”» Quick Summary Table


Feature Restrictive Cardiomyopathy Constrictive Pericarditis


Primary problem Myocardium stiff Pericardium rigid

Ventricular interdependence Absent Present

Pericardial thickness Normal Thickened / calcified

Atria Marked enlargement Mild–moderate enlargement

ECG Low voltage (amyloid) Usually normal voltage

Echo hallmark Biatrial enlargement Septal bounce + respiratory variation

Catheter hallmark No discordance Ventilatory discordance

Treatment Disease specific ± transplant Pericardiectomy (curative)

Prognosis Chronic progressive Often reversible




---


Final Takeaway


RCM and CP may look alike, but one is a myocardial disease with limited treatment options, while the other is a mechanical pericardial disease that can be surgically cured.

Accurate differentiation using echo, MRI, and invasive hemodynamics is essential for delivering the correct therapy.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...